105 related articles for article (PubMed ID: 11252167)
41. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
Schreiber CA; Sakuma T; Izumiya Y; Holditch SJ; Hickey RD; Bressin RK; Basu U; Koide K; Asokan A; Ikeda Y
PLoS Pathog; 2015 Aug; 11(8):e1005082. PubMed ID: 26244496
[TBL] [Abstract][Full Text] [Related]
42. Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts.
Visconte V; Tabarroki A; Zhang L; Parker Y; Hasrouni E; Mahfouz R; Isono K; Koseki H; Sekeres MA; Saunthararajah Y; Barnard J; Lindner D; Rogers HJ; Tiu RV
J Hematol Oncol; 2014 Dec; 7():89. PubMed ID: 25481243
[TBL] [Abstract][Full Text] [Related]
43. The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.
Webb TR; Joyner AS; Potter PM
Drug Discov Today; 2013 Jan; 18(1-2):43-9. PubMed ID: 22885522
[TBL] [Abstract][Full Text] [Related]
44. Mer1p is a modular splicing factor whose function depends on the conserved U2 snRNP protein Snu17p.
Spingola M; Armisen J; Ares M
Nucleic Acids Res; 2004; 32(3):1242-50. PubMed ID: 14973223
[TBL] [Abstract][Full Text] [Related]
45. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.
Quesada V; Conde L; Villamor N; Ordóñez GR; Jares P; Bassaganyas L; Ramsay AJ; Beà S; Pinyol M; Martínez-Trillos A; López-Guerra M; Colomer D; Navarro A; Baumann T; Aymerich M; Rozman M; Delgado J; Giné E; Hernández JM; González-Díaz M; Puente DA; Velasco G; Freije JM; Tubío JM; Royo R; Gelpí JL; Orozco M; Pisano DG; Zamora J; Vázquez M; Valencia A; Himmelbauer H; Bayés M; Heath S; Gut M; Gut I; Estivill X; López-Guillermo A; Puente XS; Campo E; López-Otín C
Nat Genet; 2011 Dec; 44(1):47-52. PubMed ID: 22158541
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
[TBL] [Abstract][Full Text] [Related]
47. Rare SF3B1 R625 mutations in cutaneous melanoma.
Kong Y; Krauthammer M; Halaban R
Melanoma Res; 2014 Aug; 24(4):332-4. PubMed ID: 24709888
[TBL] [Abstract][Full Text] [Related]
48. Molecular characterization of a novel, widespread nuclear protein that colocalizes with spliceosome components.
Schmidt-Zachmann MS; Knecht S; Krämer A
Mol Biol Cell; 1998 Jan; 9(1):143-60. PubMed ID: 9436997
[TBL] [Abstract][Full Text] [Related]
49. The kinase DYRKIA regulates pre-mRNA splicing in spermatogonia and proliferation of spermatogonia and Sertoli cells by phosphorylating a spliceosomal component, SAP155, in postnatal murine testes.
Eto K; Sonoda Y; Abe S
Mol Cell Biochem; 2011 Sep; 355(1-2):217-22. PubMed ID: 21553260
[TBL] [Abstract][Full Text] [Related]
50. Cloning the cDNA for murine U2 snRNP-A' gene and its differential expression in lymphocyte development.
Antica M; Kusic B; Hranilovic D; Dietz AB; Vuk-Pavlovic S
Immunol Lett; 2002 Jul; 82(3):217-23. PubMed ID: 12036604
[TBL] [Abstract][Full Text] [Related]
51. Splicing factor 3B1 hypomethylation is associated with altered SF3B1 transcript expression in older humans.
Holly AC; Pilling LC; Hernandez D; Lee BP; Singleton A; Ferrucci L; Melzer D; Harries LW
Mech Ageing Dev; 2014 Jan; 135():50-6. PubMed ID: 24463145
[TBL] [Abstract][Full Text] [Related]
52. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.
Visconte V; Makishima H; Jankowska A; Szpurka H; Traina F; Jerez A; O'Keefe C; Rogers HJ; Sekeres MA; Maciejewski JP; Tiu RV
Leukemia; 2012 Mar; 26(3):542-5. PubMed ID: 21886174
[No Abstract] [Full Text] [Related]
53. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
[TBL] [Abstract][Full Text] [Related]
54. Chronic lymphocytic leukemia with SF3B1 mutation.
Quesada V; Ramsay AJ; Lopez-Otin C
N Engl J Med; 2012 Jun; 366(26):2530. PubMed ID: 22738114
[No Abstract] [Full Text] [Related]
55. Identification of four genes required for mammalian blastocyst formation.
Maserati M; Dai X; Walentuk M; Mager J
Zygote; 2014 Aug; 22(3):331-9. PubMed ID: 23211737
[TBL] [Abstract][Full Text] [Related]
56. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).
Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
[TBL] [Abstract][Full Text] [Related]
57. CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing.
Serrat X; Kukhtar D; Cornes E; Esteve-Codina A; Benlloch H; Cecere G; Cerón J
PLoS Genet; 2019 Oct; 15(10):e1008464. PubMed ID: 31634348
[TBL] [Abstract][Full Text] [Related]
58. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications.
Damm F; Thol F; Kosmider O; Kade S; Löffeld P; Dreyfus F; Stamatoullas-Bastard A; Tanguy-Schmidt A; Beyne-Rauzy O; de Botton S; Guerci-Bresler A; Göhring G; Schlegelberger B; Ganser A; Bernard OA; Fontenay M; Heuser M
Leukemia; 2012 May; 26(5):1137-40. PubMed ID: 22064355
[No Abstract] [Full Text] [Related]
59. Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
Paolella BR; Gibson WJ; Urbanski LM; Alberta JA; Zack TI; Bandopadhayay P; Nichols CA; Agarwalla PK; Brown MS; Lamothe R; Yu Y; Choi PS; Obeng EA; Heckl D; Wei G; Wang B; Tsherniak A; Vazquez F; Weir BA; Root DE; Cowley GS; Buhrlage SJ; Stiles CD; Ebert BL; Hahn WC; Reed R; Beroukhim R
Elife; 2017 Feb; 6():. PubMed ID: 28177281
[TBL] [Abstract][Full Text] [Related]
60. Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1).
Gupta AK; Murthy T; Paul KV; Ramirez O; Fisher JB; Rao S; Rosenberg AB; Seelig G; Minella AC; Pillai MM
Nucleic Acids Res; 2019 Jan; 47(2):970-980. PubMed ID: 30462273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
